New: Introducing the Finviz Crypto Map

Connect Biopharma Holdings Limited

Contributing Author

Recent Articles by Connect Biopharma Holdings Limited

Jul-22	Connect Biopharma Appoints Industry Veteran Jim Schoeneck to its Board of Directors CNTB GlobeNewswire
Jul-21	Connect Biopharma Announces Plans to Terminate its American Depositary Receipt Program and Directly List its Ordinary Shares on Nasdaq CNTB GlobeNewswire
Jul-18	Connect Biopharma to Participate in the BTIG Virtual Biotechnology Conference CNTB GlobeNewswire
Jul-17	Connect Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement CNTB GlobeNewswire
Jul-09	Connect Biopharma's Exclusive Licensee in China, Simcere Pharmaceutical, Announced Submission of its New Drug Application for Rademikibart for the Treatment of Atopic Dermatitis in China CNTB GlobeNewswire
Jun-13	Connect Biopharma Presents Data Supporting Rademikibart at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress CNTB GlobeNewswire
Jun-03	Connect Biopharma Announces Two Oral Presentations at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress CNTB GlobeNewswire
May-28	Connect Biopharma to Present at Two Upcoming Investor Conferences in June CNTB GlobeNewswire
May-20	Connect Biopharma Presents Data Supporting Development of Rademikibart at the American Thoracic Society (ATS) 2025 International Conference CNTB GlobeNewswire
May-15	Connect Biopharma Reports First Quarter 2025 Financial Results and Provides Business Update CNTB GlobeNewswire
May-14	Connect Biopharma Initiates Phase 2 Seabreeze STAT COPD Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in COPD CNTB GlobeNewswire
May-13	Connect Biopharma Initiates Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Asthma CNTB GlobeNewswire

Affiliate • Advertise • Theme Settings • Contact • Blog • Help • Privacy • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.